1
|
Nettis E, Foti C, Ambrifi M, Baiardini I, Bianchi L, Borghi A, Caminati M, Canonica GW, Casciaro M, Colli L, Colombo G, Corazza M, Cristaudo A, De Feo G, De Pita' O, Di Gioacchino M, Di Leo E, Fassio F, Gangemi S, Gatta A, Hansel K, Heffler E, Incorvaia C, Napolitano M, Patruno C, Peveri S, Pigatto PD, Quecchia C, Radice A, Ramirez GA, Romita P, Rongioletti F, Rossi O, Savi E, Senna G, Triggiani M, Zucca M, Maggi E, Stingeni L. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology. Clin Mol Allergy 2020; 18:8. [PMID: 32390768 PMCID: PMC7201804 DOI: 10.1186/s12948-020-00123-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Accepted: 04/25/2020] [Indexed: 12/12/2022] Open
Abstract
Background Urticaria is a disorder affecting skin and mucosal tissues characterized by the occurrence of wheals, angioedema or both, the latter defining the urticaria-angioedema syndrome. It is estimated that 12–22% of the general population has suffered at least one subtype of urticaria during life, but only a small percentage (estimated at 7.6–16%) has acute urticaria, because it is usually self-limited and resolves spontaneously without requiring medical attention. This makes likely that its incidence is underestimated. The epidemiological data currently available on chronic urticaria in many cases are deeply discordant and not univocal, but a recent Italian study, based on the consultation of a national registry, reports a prevalence of chronic spontaneous urticaria of 0.02% to 0.4% and an incidence of 0.1–1.5 cases/1000 inhabitants/year. Methods We reviewed the recent international guidelines about urticaria and we described a methodologic approach based on classification, pathophysiology, impact on quality of life, diagnosis and prognosis, differential diagnosis and management of all the types of urticaria. Conclusions The aim of the present document from the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC) and the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA) is to provide updated information to all physicians involved in diagnosis and management of urticaria and angioedema.
Collapse
Affiliation(s)
- Eustachio Nettis
- 1Department of Emergency and Organ Transplantation, School and Chair of Allergology and Clinical Immunology, University of Bari - Aldo Moro, Bari, Italy
| | - Caterina Foti
- 2Department of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari, Bari, Italy
| | - Marina Ambrifi
- 3San Gallicano Dermatological Institute -IRCCS, Rome, Italy
| | - Ilaria Baiardini
- 4Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
| | - Leonardo Bianchi
- 5Section of Dermatology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Alessandro Borghi
- 6Section of Dermatology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - Marco Caminati
- 7Asthma Center and Allergy Unit, University of Verona and General Hospital, Verona, Italy
| | - Giorgio Walter Canonica
- 4Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.,8Personalized Medicine, Asthma and Allergy, IRCCS Humanitas, Rozzano, Milan, Italy
| | - Marco Casciaro
- 9School and Division of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - Laura Colli
- 10Department of Biomedical, Surgical and Dental Sciences, Clinical Dermatology, IRCCS Galeazzi Orthopaedic Institute, University of Milan, Milan, Italy
| | - Giselda Colombo
- 11Unit of Immunology, Rheumatology Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
| | - Monica Corazza
- 6Section of Dermatology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | | | - Giulia De Feo
- 12Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy
| | - Ornella De Pita'
- 13Clinical Pathology and Immune Inflammatory Disease of the Skin, Cristo Re Hospital, Rome, Italy
| | - Mario Di Gioacchino
- 14Department of Medicine and Science on Ageing, School of Medicine, G. d'Annunzio University, Chieti-Pescara, Italy
| | - Elisabetta Di Leo
- Section of Allergy and Clinical Immunology, Unit of Internal Medicine, "F. Miulli" Hospital, Strada Provinciale per Santeramo Km 4.100, Acquaviva Delle Fonti (BA), Italy
| | - Filippo Fassio
- Allergy and Clinical Immunology Unit, Azienda USL Toscana Centro, Florence, Italy
| | - Sebastiano Gangemi
- 9School and Division of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - Alessia Gatta
- 14Department of Medicine and Science on Ageing, School of Medicine, G. d'Annunzio University, Chieti-Pescara, Italy
| | - Katharina Hansel
- 5Section of Dermatology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Enrico Heffler
- 4Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.,8Personalized Medicine, Asthma and Allergy, IRCCS Humanitas, Rozzano, Milan, Italy
| | | | - Maddalena Napolitano
- 18Section of Dermatology, Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy
| | - Cataldo Patruno
- 19Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy
| | - Silvia Peveri
- Allergy Department Unit, Piacenza Hospital, Piacenza, Italy
| | - Paolo Daniele Pigatto
- 10Department of Biomedical, Surgical and Dental Sciences, Clinical Dermatology, IRCCS Galeazzi Orthopaedic Institute, University of Milan, Milan, Italy
| | - Cristina Quecchia
- 21Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy
| | - Anna Radice
- 22Immunoallergology Unit, Careggi University Hospital, Florence, Italy
| | - Giuseppe Alvise Ramirez
- 11Unit of Immunology, Rheumatology Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
| | - Paolo Romita
- 2Department of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari, Bari, Italy
| | - Franco Rongioletti
- Dermatological Clinic/UC of Dermatology, Department of Medical Science and Public Health, AOU Cagliari, Cagliari, Italy
| | - Oliviero Rossi
- 22Immunoallergology Unit, Careggi University Hospital, Florence, Italy
| | - Eleonora Savi
- Allergy Department Unit, Piacenza Hospital, Piacenza, Italy
| | - Gianenrico Senna
- 7Asthma Center and Allergy Unit, University of Verona and General Hospital, Verona, Italy
| | - Massimo Triggiani
- 12Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy
| | - Myriam Zucca
- Dermatological Clinic/UC of Dermatology, Department of Medical Science and Public Health, AOU Cagliari, Cagliari, Italy
| | - Enrico Maggi
- 24Department of Experimental and Clinical Medicine and Center of Excellence for Research, Transfer and High Education DENOTHE of the University of Florence, Florence, Italy
| | - Luca Stingeni
- 5Section of Dermatology, Department of Medicine, University of Perugia, Perugia, Italy
| |
Collapse
|
2
|
Foti C, Balato N, Cristaudo A, Patruno C, Pigatto P, Ambrifi M, Bufano T, Damiani G, De Rocco M, Diani M, Napolitano M, Romita P. Multicenter clinical trial on a permanent hair dye containing paratoluenediamine. Ital J Dermatol Venerol 2018; 153:464-468. [PMID: 29767482 DOI: 10.23736/s0392-0488.18.05976-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Adverse reactions to hair dyes are frequent and usually caused by sensitization to paraphenylenediamine (PPD). The aim of the study was to evaluate the tolerability of a PPD-free permanent hair dye (Shine On, BioNike, Milan, Italy) containing paratoluenediamine (PTD) in a group of subjects sensitized to PPD. METHODS The trial, which carried out at four dermatology centers, included subjects sensitized to PPD that turned out negative to patch testing to PTD. The subjects underwent to an open test consisting in the application of two hair dye colors of the product under examination. Finally, subjects who were negative upon the open test were offered to undergo the usage test with the dye, with dermatological evaluations carried out 48 and 96 hours after product application. RESULTS Sixty subjects were enrolled. They underwent the open test with two shades of dyes: "color 1 - black," the dye color with the highest concentration of color intermediates, and "color 7.3 - golden blonde," the dye color with the highest number of chemically different color intermediates. No reactions occurred with "color 7.3 - golden blonde," while 3 cases (3 out of 60) showed erythema and edema reactions to color 1. The hair dye usage test was negative for all the 21 subjects that were enrolled. CONCLUSIONS The hair dye evaluated in this study (Shine On, BioNike) can be a valid alternative for subjects sensitized to PPD.
Collapse
Affiliation(s)
- Caterina Foti
- Department of Biomedical Science and Human Oncology, Clinic of Dermatology, University of Bari, Bari, Italy
| | - Nicola Balato
- Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy
| | - Antonio Cristaudo
- Service of Occupational and Environmental Allergic Dermatology, San Gallicano Dermatology Institute for Research and Care, Rome, Italy
| | - Cataldo Patruno
- Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy
| | - Paolo Pigatto
- Department of Medical, Surgical and Dental Biosciences, Galeazzi Hospital, University of Milan, Milan, Italy
| | - Marina Ambrifi
- Service of Occupational and Environmental Allergic Dermatology, San Gallicano Dermatology Institute for Research and Care, Rome, Italy
| | - Tamara Bufano
- Department of Biomedical Science and Human Oncology, Clinic of Dermatology, University of Bari, Bari, Italy
| | - Giovanni Damiani
- Department of Medical, Surgical and Dental Biosciences, Galeazzi Hospital, University of Milan, Milan, Italy
| | - Mariagrazia De Rocco
- Service of Occupational and Environmental Allergic Dermatology, San Gallicano Dermatology Institute for Research and Care, Rome, Italy
| | - Marco Diani
- Department of Medical, Surgical and Dental Biosciences, Galeazzi Hospital, University of Milan, Milan, Italy
| | - Maddalena Napolitano
- Vincenzo Tiberio Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
| | - Paolo Romita
- Department of Biomedical Science and Human Oncology, Clinic of Dermatology, University of Bari, Bari, Italy -
| |
Collapse
|
3
|
Latini A, Orsini D, Ambrifi M, Colafigli M, Zaccarelli M, Cristaudo A. Classical Kaposi's sarcoma concurrent with ledipasvir-sofosbuvir therapy for hepatitis C infection. GIORN ITAL DERMAT V 2017; 154:593-594. [PMID: 29192474 DOI: 10.23736/s0392-0488.17.05788-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Alessandra Latini
- Unit of Infectious Dermatology and Allergology, San Gallicano Institute for Cancer Research and Care, Rome, Italy
| | - Diego Orsini
- Unit of Infectious Dermatology and Allergology, San Gallicano Institute for Cancer Research and Care, Rome, Italy -
| | - Marina Ambrifi
- Unit of Infectious Dermatology and Allergology, San Gallicano Institute for Cancer Research and Care, Rome, Italy
| | - Manuela Colafigli
- Unit of Infectious Dermatology and Allergology, San Gallicano Institute for Cancer Research and Care, Rome, Italy
| | - Mauro Zaccarelli
- Clinical Department, "Lazzaro Spallanzani" National Institute for Infectious Diseases, Rome, Italy
| | - Antonio Cristaudo
- Unit of Infectious Dermatology and Allergology, San Gallicano Institute for Cancer Research and Care, Rome, Italy
| |
Collapse
|
4
|
Ambrifi M, Dona' MG, Tedesco M, Latini A, Cota C, Giuliani M, Benevolo M, Gheit T, Tommasino M, Cristaudo A. Lichen Sclerosus in stable sexual partners: etiologic correlation or mere coincidence? GIORN ITAL DERMAT V 2017; 152:92-94. [PMID: 27978615 DOI: 10.23736/s0392-0488.16.05238-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Marina Ambrifi
- Infectious Dermatology and Allergology Unit (STI/HIV Unit), San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
| | - Maria G Dona'
- Infectious Dermatology and Allergology Unit (STI/HIV Unit), San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
| | - Marinella Tedesco
- Plastic Surgery Department, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
| | - Alessandra Latini
- Infectious Dermatology and Allergology Unit (STI/HIV Unit), San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
| | - Carlo Cota
- Dermatopathology Division, San Gallicano Dermatological Institute, IRCCS, Rome, Italy
| | - Massimo Giuliani
- Infectious Dermatology and Allergology Unit (STI/HIV Unit), San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
| | - Maria Benevolo
- Pathology Department, Regina Elena National Cancer Institute, IRCCS, Rome, Italy
| | - Tarik Gheit
- Infections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France
| | - Massimo Tommasino
- Infections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France
| | - Antonio Cristaudo
- Infectious Dermatology and Allergology Unit (STI/HIV Unit), San Gallicano Dermatologic Institute, IRCCS, Rome, Italy -
| |
Collapse
|
5
|
Ambrifi M. Attualit� sul Lichen Sclerosus genitale. GIOG 2017. [DOI: 10.11138/giog/2017.39.2.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Paolino G, Didona D, Clerico R, Corsetti P, Ambrifi M, Bottoni U, Calvieri S. Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study. Cutis 2016; 97:E12-E16. [PMID: 27416091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Imatinib mesylate (IM) represents the first-line treatment of patients with chronic myeloid leukemia (CLM) or gastrointestinal stromal tumor (GIST). It presents several side effects. However, less than 10% are nonhematologic including nausea, vomiting, diarrhea, muscle cramps, and cutaneous reactions. The aim of our study was to identify data regarding IM cutaneous adverse effects (AEs) to improve the clinical diagnosis and management of the more frequent side effects. Skin examination should be done before and during IM treatment so that AEs can be diagnosed and treated early with less impact on chemotherapy treatments and on the quality of life of the patient.
Collapse
Affiliation(s)
- Giovanni Paolino
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy
| | - Dario Didona
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy
| | - Rita Clerico
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy
| | - Paola Corsetti
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy
| | - Marina Ambrifi
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy
| | - Ugo Bottoni
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy; University Magna Graecia, Catanzaro, Italy
| | - Stefano Calvieri
- Dermatology Clinic, Department of Internal Medicine and Medical Specialties, University of Rome, Italy
| |
Collapse
|
7
|
Paolino G, Didona D, Clerico R, DE Vita G, Corsetti P, Ambrifi M, Cantisani C, Bottoni U, Richetta AG, Lopez T, Calvieri S. Cancer surveillance series: role of demographic aspects, altitude and latitude in the extracutaneous malignant melanoma in a residential study. GIORN ITAL DERMAT V 2016; 151:133-139. [PMID: 26889723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
BACKGROUND Extracutaneous melanoma (ECM) is a very rare malignancy and its biology differs from that of cutaneous melanoma. Residential studies can offer an important contribution to the study of this disease. METHODS We characterized the distribution of ECM according to residential and demographic baseline characteristics. We computer-searched patients that removed an ECM, and we analyzed all demographic and residential parameters. Disease free survival (DFS), date of death or last follow-ups were evaluated. The same parameters were analyzed using hazards-regression. Finally, we used the multiple regressions between DFS and the predictors. RESULTS A total of 44 ECM patients were included in our analysis. Median DFS was of 10 months; at Log-Rank Test and Cox-hazard regression, the variable age (P<0.01; P<0.004) and latitude (P<0.02; P<0.006) reached a statistical significance; at multiple logistic regression, the significance was instead maintained only for the variable age. General OS was of 42 months at Log-Rank Test age (P<0.001), as well as latitude (P<0.006) maintained its significance at hazard-regression. CONCLUSIONS Demographic and residential aspects can play an important role in the study of this rare disease, supporting the assumption that ECM are generated by processes actually unknown, as demonstrated in our results compared with those of the literature.
Collapse
Affiliation(s)
- Giovanni Paolino
- Dermatologic Clinic, La Sapienza University of Rome, Rome, Italy -
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Cristaudo A, Francesconi L, Ambrifi M, Frasca M, Cavallotti C, Sperduti E. Efficacy of an emollient dermoprotective cream in the treatment of elderly skin affected by xerosis. GIORN ITAL DERMAT V 2015; 150:297-302. [PMID: 25946673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
AIM Xerosis cutis is a frequent condition in the elderly and the topical treatments are aimed to maintain a balance between the physiological components of the epidermis and an optimal moisturization. The aim was to evaluate the efficacy of a dermoprotective cream, glycerol and paraffin-based, in the treatment of individuals affected by senile xerosis. METHODS The patients were recruited at the Professional Dermatology and Allergology Outpatient Clinic of the San Gallicano Dermatological Institute of Rome, between 1st January 2013 and 30th September 2014. To assess the efficacy of the cream, two different areas of treatment were identified in each patient upper the limbs. All patients were staged at baseline (T0) and evaluated after 14 days (T1) and 28 days (T2) of topical treatment, using five clinical parameters: scaling, sensation of skin tightness, presence of fissuring and excoriations from scratching and erythema. The itching degree was also evaluated using a 10-steps analogical scale. RESULTS Fifty patients with xerosis, 25 with a severe and 25 with a moderate form, over 60 were recruited and evaluated. Median age was 65 years (IQR=61-70). After 28 day of topical administration of the cream, the 54.0% of patients showed the absence of signs of xerosis, the 44.0% a mild form and the 2.0% (one patient) a moderate form. Consistently, a progressive and significative reduction of itching and transepidermal water loss (TEWL), and an improvement in skin hydration was also measured. A good profile of tolerability and no episodes of undesirable side effects, was also observed. CONCLUSION The topical daily use of a cream glycerol and paraffin-based, seem to able to control the xerosis in elderly patients, with a significant reduction of all associated signs and symptoms. Further additional data should be collected to better confirm the role of the topical treatment in the control of disease.
Collapse
Affiliation(s)
- A Cristaudo
- Operative Unit of Clinical Dermatology, Dermatological Institute, San Gallicano (IRCCS) Rome, Italy -
| | | | | | | | | | | |
Collapse
|
9
|
Bottoni U, Paolino G, Ambrifi M, Didona D, Albanesi M, Clerico R, Lido P, Brachini A, Corsetti P, Richetta AG, Cantisani C, Calvieri S. Association between autoimmune disease and cutaneous melanoma with regard to melanoma prognosis. Clin Exp Dermatol 2015; 40:254-9. [PMID: 25475359 DOI: 10.1111/ced.12531] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/16/2014] [Indexed: 12/29/2022]
Abstract
BACKGROUND An association between autoimmune disease and malignant melanoma (MM) has often been reported in the literature as a positive prognostic factor for MM. Consequently, we evaluated the influence of different autoimmune diseases on the prognosis of MM. AIM To evaluate the prognosis of patients with MM who also had an autoimmune disorder, whether tumour-associated, paraneoplastic or drug-induced. METHODS Autoimmune diseases were classified and analysed as tumour-associated, paraneoplastic or drug-induced. Patients were enrolled according to their clinicopathological features and matched with control groups. Kaplan-Meier analysis was used to estimate disease-free survival (DFS) and overall survival (OS), and log-rank test was used to evaluate differences between the survival curves. RESULTS In total, 49 patients with MM and tumour-associated autoimmune disease were included in our analysis. No case of paraneoplastic autoimmune disease was detected. The survival analyses showed a range of results, from a worsening of DFS and OS to a lack of any difference. In a second analysis, we separately analysed patients who developed autoimmune disorders after starting adjuvant therapy with interferon-α; we did not find significant differences between these patients and the untreated patients. CONCLUSIONS Autoimmune disease, whether tumour-associated or drug-induced, was not associated with better prognosis in patients with MM. The results suggest that the reported relationship between autoimmunity and MM may be a result of individual variation in sensitivity to the autoimmune disease, the tumour or the treatments.
Collapse
Affiliation(s)
- U Bottoni
- Department of Dermtology, University Magna Graecia, Catanzaro, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Cantisani C, Ambrifi M, Frascani F, Fazia G, Paolino G, Lisi R, Calvieri S. Glaucoma eye drops adverse skin reactions. ACTA ACUST UNITED AC 2014; 8:192-5. [PMID: 25487259 DOI: 10.2174/1872213x09666141209093732] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 12/07/2014] [Accepted: 11/13/2014] [Indexed: 11/22/2022]
Abstract
The term "Glaucoma" is used to describe a number of diseases of the eye characterized by a particular form of optic nerve damage that is often associated with high intraocular pressure (IOP). The open-angle glaucoma is the most common form that is also referred to as chronic glaucoma. This is described as an optic neuropathy with multifactorial nature in which there is a loss of characteristics of the optic nerve fibers. Therapeutic options for the treatment of this disease are different, you can take advantage of eye drops, laser therapy and conventional surgery or more combined treatments. Medicated eye drops are the most common way to treat glaucoma. Although eye drops are widely used, adverse reactions are not frequently observed and described. In particular, the adverse skin reactions are not frequently described in the literature, but often seen in dermatologic clinic, we reported their skin reactions and possible alternative treatments described in literature and their patent applications.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Stefano Calvieri
- Department of Dermatology and Plastic Surgery, Sapienza University, Policlinico Umberto I Hospital, Rome, Italy.
| |
Collapse
|
11
|
Miraglia E, Cantisani C, Giustini S, Ambrifi M, Soda G, Calvieri S. Basal cell carcinomas in a young woman with Steinert's disease. Dermatol Online J 2014; 20:13030/qt15k425wz. [PMID: 25148278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2014] [Accepted: 08/15/2014] [Indexed: 06/03/2023] Open
Abstract
Steinert's disease or Myotonic dystrophy type I (DM1) is an autosomal dominant disease characterized by myotonia, muscular dystrophy, cataracts, hypogonadism, frontal balding, and electrocardiographic alterations.Several tumors have been associated with DM1 such as pilomatricoma, thymomas and insulinomas. Herein, we describe the unusual onset of multiple basal cell carcinomas in a young woman with DM1.
Collapse
|
12
|
Bottoni U, Clerico R, Paolino G, Corsetti P, Ambrifi M, Brachini A, Richetta A, Nisticò S, Pranteda G, Calvieri S. Melanoma and IFN alpha: potential adjuvant therapy. J BIOL REG HOMEOS AG 2014; 28:271-279. [PMID: 25001659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Interferon alpha (IFNalpha) is the most used adjuvant treatment in clinical practice for melanoma (MEL) high-medium risk patients; however, the use of IFNalpha has yielded conflicting data on Overall Survival (OS) and disease free survival (DFS) rates. Starting from these considerations, we carried out an analysis on our MEL patients who received adjuvant IFNalpha therapy, in order to identify possible predictors for their outcome. A total of 140 patients were included in our analysis. Patients with Breslow thickness ≤2.00 mm presented a significantly longer mean DFS than patients with Breslow ≥2.01 mm (p = 0.01). Using non- parametric Spearmans Coefficient test we found association between DFS and Breslow thickness (p < 0.001) and between DFS and ulceration (p = 0.03). Performing Multiple Regression test, Breslow thickness (p < 0.001) remained the only statistically significant predictor. From the OS analysis we found that patients with lower Breslow values ≤ 2.00 mm (p < 0.0001), and absence of ulceration (p <0.004) showed a significantly better long-term survival. From the current analysis we found that the use of low dose IFNalpha is justified only for cutaneous melanoma ≤ 4.01 mm that was not ulcerated; patients with Breslow ≥ 4.01 mm, in our opinion, should not carry out adjuvant treatment with low dose IFNalpha, because its side effects could be higher than the its benefits.
Collapse
Affiliation(s)
- U Bottoni
- Department of Health Sciences, University Magna Graecia, Viale Europa, Germaneto, Catanzaro, Italy
| | - R Clerico
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| | - G Paolino
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| | - P Corsetti
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| | - M Ambrifi
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| | - A Brachini
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| | - A Richetta
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| | - S Nisticò
- Department of Health Sciences, University Magna Graecia, Viale Europa, Germaneto, Catanzaro, Italy
| | - G Pranteda
- Dermatology Unit, NESMOS Department, II School of Medicine, Sapienza University Rome, S. Andrea Hospital, Via Grottarossa, Rome, Italy
| | - S Calvieri
- Unit of Dermatology, Umberto I Polyclinic, La Sapienza University, Via del Policlinico, Rome, Italy
| |
Collapse
|
13
|
Miraglia E, Ambrifi M, Persechino F, Visconti B, Calvieri S, Giustini S. An unusual skin manifestation in a patient with Peutz-Jeghers Syndrome. Acta Dermatovenerol Croat 2014; 22:213-214. [PMID: 25230064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- Emanuele Miraglia
- Emanuele Miraglia, MD, Department of Dermatology, Policlinico Umberto I, Sapienza, Viale del Policlinico 155, I-00161 Rome, Italy;
| | | | | | | | | | | |
Collapse
|
14
|
Miraglia E, Cantisani C, Giustini S, Ambrifi M, Soda G, Calvieri S. Basal cell carcinomas in a young woman with Steinert’s disease. Dermatol Online J 2014. [DOI: 10.5070/d3208023530] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
15
|
Bottoni U, Clerico R, Paolino G, Ambrifi M, Luci C, Corsetti P, Calvieri S. Appearance of malignant melanoma after a non-cutaneous cancer diagnosis. Ecancermedicalscience 2013; 7:315. [PMID: 23653675 PMCID: PMC3640549 DOI: 10.3332/ecancer.2013.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2013] [Indexed: 11/26/2022] Open
Abstract
Background: The aim of this study is to find the associations between malignant melanoma (MM) and other non-cutaneous malignancies and to see whether there are possible correlations between them. Methods: We analysed a sample of 1720 patients collected by our melanoma database, to identify patients with both MM and non-cutaneous primary cancer (NCC). The incidence rate (IR) included in our database was calculated as the ratio between the observed patients with NCC and those with MM. Results: A total of 74 patients, with both NCC and MM, were included in our analysis, corresponding to 4.30% of patients with MM present in our melanoma database. After breast cancer (24.3%; IR = 1:4), the most common malignancies were lymphomas (14.8%; IR = 1:4), renal cell carcinoma (13.5%; IR = 1:7), thyroid cancer (9.4%; IR = 1:11), and prostatic carcinoma (8.1%; IR = 1:12), followed by other cancers. Among patients with lymphomas, most patients (72.7%) had a non-Hodgkin lymphoma. Our study shows a high coexistence of multiple malignancies in patients with MM. Conclusion: Although we cannot definitively confirm a true association between non-skin cancers and MM, we believe that there are sufficient links for further investigation in order to identify new aetiological factors and therapeutic targets for these cancers.
Collapse
Affiliation(s)
- Ugo Bottoni
- University Magna Graecia, V.le Europa, 88100 Catanzaro, Italy
| | | | | | | | | | | | | |
Collapse
|
16
|
Bottoni U, Clerico R, Paolino G, Ambrifi M, Corsetti P, Calvieri S. Predictors and survival in patients with melanoma brain metastases. Med Oncol 2013; 30:466. [PMID: 23377924 DOI: 10.1007/s12032-013-0466-2] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2012] [Accepted: 01/09/2013] [Indexed: 11/30/2022]
Abstract
Brain metastases (BM) are one of the most frequent neurological complications of cancers. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %, and many patients have subclinical BM (>73 %). We computer-searched the clinical records of all our patients registered into a database to identify patients that presented or developed BM. A total of 49 patients with melanoma BM were included in our analysis. General time to brain metastases (TTBM) was 23 months. The nonparametric test between TTBM and the single variables showed an association between TTBM and Breslow thickness (p < 0.0076; Spearman's coefficient-0.411), ulceration (p = 0.0656; Spearman's coefficient-0.287) and positive sentinel lymph node (p < 0.0015; Spearman's coefficient-0.475). Performing multiple regression, positive SLN remained the only, statistically significant, predictive variable (p < 0.01). Regarding the first melanoma site, the axial sites were more likely to develop BM than peripheral ones (p < 0.001). The analysis of brain metastasis survival (BMS) with Kaplan-Meier curves has resulted in a median survival rate of 6 months (range 1-134 months) and was strongly related to response to treatment, number of parenchymal lesions, presence or absence of symptoms. The results of the current analysis revealed clinical and primary tumor characteristics associated with the development of BM, TTBM, and BMS. The SNL was found to be the strongest predictor for BM development.
Collapse
Affiliation(s)
- Ugo Bottoni
- University Magna Graecia, V.le Europa, 88100 Catanzaro, Italy.
| | | | | | | | | | | |
Collapse
|
17
|
Clerico R, Bottoni U, Paolino G, Ambrifi M, Corsetti P, Devirgiliis V, Calvieri S. Melanoma with unknown primary: report and analysis of 24 patients. Med Oncol 2012; 29:2978-84. [DOI: 10.1007/s12032-012-0217-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2012] [Accepted: 03/12/2012] [Indexed: 11/30/2022]
|
18
|
Clerico R, Corsetti P, Ambrifi M, Paolino G, Rossi MR, Bottoni U, Calvieri S. Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea. Acta Dermatovenerol Croat 2012; 20:281-283. [PMID: 23317494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
|